Search clinical trials for: Alogliptin

Total 98 results

Dong-A ST Co., Ltd.

Completed

Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of Evogliptin 5 mg and Pioglitazone 30 mg

Type 2 Diabetes

Korea, Republic of
Dong-A ST Co., Ltd.

Completed

Pharmacokinetic and Pharmacodynamic Drug-Drug Interaction of Evogliptin and Empagliflozin or Dapagliflozin in Healthy Male Adults

Type2 Diabetes

Korea, Republic of
Chengdu Easton Biopharmaceuticals Co,Ltd

Recruiting

A Randomized, Double-blind, Placebo-controlled, Multicenter Clinical Trial to Evaluate the Clinical Efficacy and Safety of Yogliptin Tablets

Type 2 Diabetes

China
Dong-A ST Co., Ltd.

Completed

Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of Evogliptin 5mg and Glimepiride 4mg

Type2 Diabetes

Korea, Republic of
Kun-Ho Yoon
Takeda

Completed

The Practical Evidence of Antidiabetic Combination Therapy in Korea (PEAK)

Type 2 Diabetes Mellitus

Korea, Republic of
Takeda

Completed

Efficacy and Safety Study of Alogliptin and Insulin in the Treatment of Type 2 Diabetes.

Diabetes Mellitus

United States, Australia, Brazil, Chile, Guatemala, India, Mexico, New Zealand, Peru, South Africa, Czech Republic, Germany, Hungary, Netherlands, Poland, Argentina
Takeda

Completed

Study of Alogliptin Combined With Sulfonylurea in Subjects With Type 2 Diabetes Mellitus.

Diabetes Mellitus

United States, Australia, Brazil, Chile, Guatemala, India, Mexico, New Zealand, Peru, South Africa, Netherlands, Poland, United Kingdom, Argentina, Dominican Republic
Takeda

Completed

Efficacy and Safety of Alogliptin Used Combination With Thiazolidine in Participants With Type 2 Diabetes in Japan

Type 2 Diabetes Mellitus
Dong-A ST Co., Ltd.

Completed

The Pharmacokinetics/Pharmacodynamics and Safety/Tolerability of Evogliptin in Hemodialysis Patients

Hemodialysis Patients

Korea, Republic of
Dong-A ST Co., Ltd.

Completed

PK//PD/Tolerability Study of DA-1229(Evogliptin) in Renal Impaired Patients

Renal Impairment

Korea, Republic of
Takeda

Completed

Efficacy and Safety of Alogliptin Combined With Metformin in Participants With Type 2 Diabetes Mellitus

Diabetes Mellitus

United States, Australia, Brazil, Chile, Guatemala, India, Mexico, New Zealand, Peru, South Africa, Czech Republic, Germany, Hungary, Netherlands, Poland, United Kingdom, Argentina
REDNVIA Co., Ltd.

Recruiting

A Study to Evaluate the Efficacy and Safety of DA-1229 (Evogliptin) in Patient's Calcific Aortic Valve Disease With Mild to Moderate Aortic Stenosis (EVOID-AS)

Calcific Aortic Valve Disease

United States
DongGuk University

Unknown

Effect of Evogliptin on Bone Metabolism in Human

Diabetes Mellitus, Type 2 | Osteoporosis

Korea, Republic of
Kun-Ho Yoon
Takeda

Terminated

An Extension Study of PEAK Trial (PEAK-E)

Diabetes Mellitus, Type 2

Korea, Republic of
Takeda

Completed

Efficacy and Safety of Alogliptin and Metformin Fixed-Dose Combination in Participants With Type 2 Diabetes

Diabetes Mellitus

China, Taiwan, Korea, Republic of, Malaysia
Takeda

Terminated

Non-Interventional Study of the Use of Alogliptin and Alogliptin Fixed-Dose Combinations With Pioglitazone and With Metformin in Standard Clinical Practice

Diabetes Mellitus, Type 2

China, Hong Kong
Takeda

Completed

Efficacy of Alogliptin and With Pioglitazone in Patients With Type 2 Diabetes.

Diabetes Mellitus

Netherlands, Sweden
Seoul National University Hospital

Unknown

Glimepiride, Alogliptin and Alogliptin+Pioglitazone Combination

Type 2 Diabetes Mellitus
Takeda

Completed

Long-term Safety Study of Alogliptin Used in Combination With Sulfonylurea or Metformin in Participants With Type 2 Diabetes in Japan

Type 2 Diabetes Mellitus
Dong-A ST Co., Ltd.

Unknown

Observational Study to Evaluate the Efficacy and Safety of Suganon Tab. or Sugamet XR Tab.

Diabetes Mellitus, Type 2

Korea, Republic of
Asan Medical Center
REDNVIA Co., Ltd.

Not yet recruiting

Randomized, Open-label Trial of Inhibitory Effect of Evogliptin on Progression of CAVD

CAVD

Korea, Republic of
Takeda

Completed

A Study for Post-Marketing Surveillance of Nesina® Tablet Monotherapy or Combination Therapy in Participants With Type 2 Diabetes (T2DM) in South Korea

Type 2 Diabetes Mellitus

Korea, Republic of
Takeda

Completed

An Observational Study of Alogliptin Benzoate in Participants With Diabetes Mellitus Type 2

Diabetes Mellitus

Russian Federation
Takeda
Takeda Development Center Americas, Inc.

Completed

Phase 3 Alogliptin Pediatric Study

Diabetes Mellitus, Type 2

United States, Italy, Mexico, Russian Federation, Brazil, Israel, Poland
Fourth People's Hospital of Shenyang

Completed

The Effect of Alogliptin on Pulmonary Function in Obese Patients With Type 2 Diabetes Inadequately Controlled by Metformin Monotherapy

Diabetes Mellitus, Type 2
Takeda

Completed

Double-blind Comparative Study of SYR-472

Diabetes Mellitus

Japan
Shenzhen Salubris Pharmaceuticals Co., Ltd.

Completed

SAL067 Treatment in Patients With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise

Diabetes Mellitus, Type 2

China
Dong-A ST Co., Ltd.

Completed

Pharmacokinetics and Safety of Evogliptin in Subjects With Hepatic Dysfunction

Liver Dysfunction

Korea, Republic of
Takeda

Completed

Efficacy and Safety of Alogliptin Combined With Pioglitazone in Treating Subjects With Type 2 Diabetes Mellitus.

Type 2 Diabetes Mellitus

United States, Australia, Brazil, Bulgaria, Chile, Croatia, Estonia, Guatemala, India, Israel, Latvia, Mexico, New Zealand, Peru, Romania, Russian Federation, Serbia, South Africa, Ukraine
Takeda

Completed

Efficacy and Safety of Alogliptin Used Combination With Metformin in Participants With Type 2 Diabetes in Japan

Type 2 Diabetes Mellitus
Takeda

Completed

Long-term Safety Study of Alogliptin Used in Combination With Thiazolidine in Participants With Type 2 Diabetes in Japan

Type 2 Diabetes Mellitus
Takeda

Completed

Alogliptin/Pioglitazone (Liovel) Combination Tablets Survey on Long-term Use in Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Japan
Takeda

Completed

Efficacy and Safety of Alogliptin Used in Combination With Sulfonylurea in Participants With Type 2 Diabetes in Japan

Type 2 Diabetes Mellitus
Takeda

Completed

Specified Drug-Use Survey of Alogliptin and Metformin Hydrochloride Combination Tablets "Survey on Long-term Use in Type 2 Diabetes Mellitus Patients With Renal or Hepatic Impairment or Advanced Age"

Type 2 Diabetes Mellitus

Japan
Takeda

Completed

Study of Alogliptin Combined With Pioglitazone in Subjects With Type 2 Diabetes Mellitus

Diabetes Mellitus

United States, Australia, Brazil, Guatemala, India, Mexico, New Zealand, Peru, South Africa, Czech Republic, Germany, Hungary, Netherlands, Argentina
Dong-A ST Co., Ltd.

Completed

A Clinical Trial to Investigate the Efficacy and Safety of Evogliptin

Type 2 Diabetes Mellitus

Korea, Republic of
Celltrion

Completed

A Bioequivalence Study of CT-L01 Compared to Co-administration (ALO 12.5 mg and MET XR 500 mg) in Healthy Volunteers

Healthy

Korea, Republic of
University of Catanzaro

Unknown

Anti-inflammatory Status in DM2 Treated Patients (INF-DM2-Ther)

Diabetes Mellitus, Type 2

Italy
Celltrion

Completed

A Bioequivalence Study of CT-L01 Compared to Co-administration (ALO 25 mg and MET XR 1,000 mg) in Healthy Volunteers

Healthy

Korea, Republic of
Dong-A ST Co., Ltd.

Completed

A Clinical Trial to Investigate Safety/Tolerability and Pharmacokinetics of DA-1229_01(Evogliptin/Metformin XR 2.5/500 mg x 2 Tablets) Compared to Co-administration of Evogliptin 5 mg and Metformin XR 1000 mg in Healthy Male Volunteers

Type 2 Diabetes Mellitus

Korea, Republic of
Celltrion Pharm, Inc.

Active, not recruiting

A Study to Evaluate the Effect of add-on Pioglitazone or Dapagliflozin in Participants With Type 2 Diabetes Mellitus Inadequately Controlled by DPP-4 Inhibitor and Metformin Therapy (EPIDOTE)

Diabetes Mellitus, Type 2

Korea, Republic of
Takeda

Completed

Efficacy and Safety of Alogliptin in Participants With Type 2 Diabetes

Diabetes Mellitus, Type 2

Hong Kong, China, Taiwan
JW Pharmaceutical

Completed

A Study to Efficacy and Safety of CWP-0403 in Type 2 Diabetes Mellitus Patients (CWP-DIANA-301)

Type 2 Diabetes Mellitus

Korea, Republic of
Takeda

Completed

Efficacy and Safety of Alogliptin Plus Metformin in Patients With Type 2 Diabetes (AM7D)

Diabetes Mellitus, Type 2

United States, Ukraine, Israel, Mexico, Romania, Russian Federation, South Africa, Czech Republic, Puerto Rico, Poland, Hungary, Lithuania, Slovakia
Dong-A ST Co., Ltd.

Completed

A Clinical Trial to Investigate Safety/Tolerability and Pharmacokinetics of DA-1229_01 Compared to Co-administration of Evogliptin 5 mg and Metformin XR 1000 mg, and to Evaluate the Effect of Food on the Pharmacokinetics of DA-1229_01 in Healthy Male Volunteers

Type 2 Diabetes Mellitus

Korea, Republic of
Yonsei University

Unknown

To Evaluate the Effect of Nesinaact on Non-alcoholic Steatohepatitis Through MRI and Liver Fibroscan in Patients With Type 2 Diabetes

Type2 Diabetes | Non-alcoholic Steatohepatitis

Korea, Republic of
AstraZeneca

Completed

Roflumilast Plus Alogliptin Proof-of-Mechanism Study in Type2 Diabetes

Type 2 Diabetes

United States
Dong-A ST Co., Ltd.

Completed

Efficacy and Safety of Evogliptin When Added to Ongoing Metformin and Dapagliflozin Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control

Type2 Diabetes

Korea, Republic of
Dong-A ST Co., Ltd.

Completed

Efficacy and Safety of Evoglitin in Patients With Type 2 Diabetes and Non-alcoholic Fatty Liver Diseases

Type2 Diabetes | Non-Alcoholic Fatty Liver Disease

Korea, Republic of
Takeda

Completed

Long-term Safety Study of Alogliptin Used in Combination With α-glucosidase Inhibitor in Participants With Type 2 Diabetes in Japan

Type 2 Diabetes Mellitus

3

Subscribe